| Hormone Receptor-Negative | Hormone Receptor-Positive | ||||||
---|---|---|---|---|---|---|---|---|
 | Overall Survival | Breast Cancer-Specific Survival | Overall Survival | Breast Cancer-Specific Survival | ||||
Variablea | Adjusted HRs (95% CI) | P | Adjusted HRs (95% CI) | P | Adjusted HRs (95% CI) | P | Adjusted HRs (95% CI) | P |
Time Period | Â | Â | Â | Â | Â | Â | Â | Â |
2000–2009 | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
2010–2019 | 0.83 (0.71–0.97) | 0.021 | 0.83 (0.69–1.00) | 0.045 | 0.9 (0.66–1.24) | 0.525 | 0.87 (0.61–1.24) | 0.428 |
Age | Â | Â | Â | Â | Â | Â | Â | Â |
< 50 | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
≥ 50 | 1.50 (1.21–1.88) | < 0.001 | 1.33 (1.06–1.68) | 0.016 | 1.60 (1.05–2.42) | 0.027 | 1.52 (0.97–2.37) | 0.066 |
Race/Ethnicity | Â | Â | Â | Â | Â | Â | Â | Â |
Black | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
White | 0.80 (0.65–1.00) | 0.049 | 0.76 (0.59–0.97) | 0.027 | 0.74 (0.50–1.10) | 0.136 | 0.68 (0.44–1.06) | 0.086 |
Hispanic | 0.80 (0.58–1.08) | 0.149 | 0.73 (0.52–1.03) | 0.073 | 0.74 (0.41–1.32) | 0.309 | 0.74 (0.39–1.39) | 0.352 |
Other | 0.76 (0.52–1.12) | 0.173 | 0.70 (0.45–1.09) | 0.113 | 0.53 (0.28–1.04) | 0.063 | 0.56 (0.27–1.14) | 0.111 |
T Stage | Â | Â | Â | Â | Â | Â | Â | Â |
T0&T1 | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
T2 | 1.57 (1.20–2.06) | 0.001 | 1.65 (1.18–2.31) | 0.003 | 2.47 (1.51–4.02) | < 0.001 | 3.21 (1.70–6.06) | < 0.001 |
T3 | 3.94 (2.94–5.28) | < 0.001 | 4.83 (3.37–6.90) | < 0.001 | 3.91 (2.22–6.87) | < 0.001 | 5.22 (2.58–10.59) | < 0.001 |
T4 | 5.51 (3.94–7.70) | < 0.001 | 7.08 (4.78–10.49) | < 0.001 | 7.04 (3.92–12.63) | < 0.001 | 9.72 (4.69–20.14) | < 0.001 |
Node Status | Â | Â | Â | Â | Â | Â | Â | Â |
Negative | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
Positive | 2.00 (1.66–2.41) | < 0.001 | 2.23 (1.82–2.74) | < 0.001 | 2.22 (1.57–3.13) | < 0.001 | 2.27 (1.56–3.32) | < 0.001 |
Unknown | 2.07 (1.59–2.68) | < 0.001 | 1.76 (1.25–2.48) | 0.001 | 2.57 (1.63–4.05) | < 0.001 | 1.70 (0.95–3.06) | 0.076 |
Surgery Type | Â | Â | Â | Â | Â | Â | Â | Â |
BCS | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
Mastectomy | 1.39 (1.13–1.71) | 0.002 | 1.32 (1.04–1.68) | 0.024 | 1.31 (0.88–1.94) | 0.180 | 1.27 (0.80–2.00) | 0.311 |
Radiotherapy | Â | Â | Â | Â | Â | Â | Â | Â |
No/Unknown | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
Yes | 0.72 (0.60–0.86) | < 0.001 | 0.70 (0.58–0.86 | 0.001 | 0.70 (0.48–1.02) | 0.062 | 0.67 (0.44–1.02) | 0.059 |
Chemotherapy | Â | Â | Â | Â | Â | Â | Â | Â |
No/Unknown | 1 | Ref | 1 | Ref | 1 | Ref | 1 | Ref |
Yes | 0.63 (0.52–0.75) | < 0.001 | NAb | NA | 0.55 (0.38–0.79) | 0.001 | 0.70 (0.46–1.06) | 0.093 |